The WG2 Outsourcing Facilities Task Group seeks participation from industry professionals experienced and interested in developing structured product listings and marketing categories.

    The group will discuss the newly developed drug compounds manufactured in U.S. Food and Drug Administration (FDA) Outsource Facilities and how these drugs should be represented, listed and marketed within the FDA and industry systems.

    Input is needed to address the marketing categories developed by manufacturers and how these categories affect payers and national drug database vendors.

    Anyone with the desire to help craft the future of pharmaceutical marketing should plan to join the task group and attend our next call scheduled for January 7, 2020.  Register and log in to the Collaborative Workspace for upcoming meeting dates.

For problems with the site please contact us at